Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 13/20 | 0.58 |
| ▸ | KLKB1 | P03952 | 6/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4645290 | 0.89 | F10 (0.59) | F10KLKB1POLB | |
| SCHEMBL3580391 | 0.89 | POLB (0.56) | F10KLKB1POLB | |
| SCHEMBL3577875 | 0.84 | F10 (0.57) | F10KLKB1POLB | |
| SCHEMBL3589004 | 0.82 | F10 (0.52) | F10KLKB1POLB | |
| SCHEMBL3580373 | 0.80 | POLB (0.55) | F10KLKB1POLB | |
| SCHEMBL3582633 | 0.80 | POLB (0.57) | F10KLKB1POLB | |
| SCHEMBL3830271 | 0.79 | F10 (0.63) | F10KLKB1POLB | |
| SCHEMBL3577873 | 0.78 | POLB (0.53) | F10KLKB1POLB | |
| SCHEMBL3587146 | 0.78 | F10 (0.58) | F10KLKB1POLB | |
| SCHEMBL3581950 | 0.78 | POLB (0.57) | F10KLKB1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732481-B2 | Prolinylarylacetamides | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-06-08 | — | — | US | claimed |
| US-20070185189-A1 | Prolinylarylacetamides | MERCK PATENT GMBH (DE) | 2007-08-09 | — | — | US | claimed |
| US-7732481-B2 | Prolinylarylacetamides | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-06-08 | — | — | US | disclosed |
| US-20070185189-A1 | Prolinylarylacetamides | MERCK PATENT GMBH (DE) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185189-A1 | Prolinylarylacetamides | F12, F11, F2 | F10 5/4885KLKB1 1086/4885POLB 3435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.